Regeneron Pharmaceuticals, Inc. (REGN) Tops Q4 EPS by 36c

February 14, 2013 6:36 AM

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q4 EPS of $1.47 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found